Skip to content
Healthcare & Life Sciences — MedTech

AI strategy for MedTech. Navigate dual compliance: EU AI Act × MDR.

The intersection of EU AI Act and Medical Device Regulation creates complex dual compliance. MDCG 2025-6 provides guidance on bias mitigation and transparency. The proposal to integrate conformity assessments is positive — but in practice it requires expertise that most product teams do not have in-house.

Sector Recognition

Four pressure points making AI governance urgent

1. Dual compliance obligation: EU AI Act + MDR creates complex compliance requirements. MDCG 2025-6 provides guidance but every AI update can require a new conformity pathway. The agile update model of software clashes with the static certification model of MDR.

2. Software as Medical Device (SaMD): AI algorithms in medical devices must be MDR-certified. Every significant update potentially requires recertification. This slows innovation unless governance-by-design is implemented.

3. Bias mitigation: EU AI Act explicitly requires bias mitigation in high-risk medical AI. This must be integrated into the Quality Management System — not as a separate exercise but as part of product development.

4. Interoperability: Medical AI must integrate seamlessly with diverse EHR systems. HL7 FHIR compliance and standardisation are prerequisites for market acceptance and clinical adoption.

AI Use Cases

Five applications with measurable impact

Transformational

Smart Implant Monitoring

Continuous vital function monitoring

AI in implants for real-time monitoring of patient data. Detects anomalies early and alerts clinicians. Requires MDR certification and EU AI Act compliance.

Strategic

Diagnostic Imaging AI

20–30% more accurate detection

AI analysis of MRI, CT and X-ray images. Improves detection of abnormalities and supports radiologists in complex assessments.

Strategic

Wearable Health Analytics

Preventive care at scale

Pattern recognition in data from wearables and sensors. Identifies health risks before symptoms appear.

Quick Win

Quality Management AI

50% more efficient QMS

MDR-compliant quality control via AI automation of documentation, deviation management and CAPA processes.

Quick Win

Regulatory Intelligence

Real-time regulation monitoring

AI monitoring of MDR, EU AI Act, IVDR and national regulation. Alerts on relevant changes and impact assessments.

Regulatory Landscape

Regulation. Your obligations.

RegulationRequirementDeadlineAlphaIndigo Service
EU AI Act + MDRDual compliance — integrated conformity assessmentAugust 2026AI Opportunity Scan
MDCG 2025-6AI in medical devices — bias mitigation and transparency2025AI Steward
IVDRIn vitro diagnostics — AI in diagnostic testsOngoingAI Steward
NEN-EN-IEC 62304Software lifecycle for medical devicesOngoingAI Academy
ISO 13485Quality Management System for medical devicesOngoingAI Opportunity Scan
Perspective

MDCG 2025-6: the bridge between two worlds

The publication of MDCG 2025-6 marks a significant moment for the MedTech sector. For the first time, European authorities provide concrete guidance on the interaction between the EU AI Act and the Medical Device Regulation. The proposal to integrate conformity assessments — one assessment covering both frameworks — is positive.

But the reality is more complex. Every significant AI update can trigger a new conformity pathway under MDR. The agile update model of software development clashes directly with the static certification model of medical devices. Governance-by-design — building compliance into the development process itself — is the only scalable solution.

MedTech companies that implement this first are building not only regulatory advantage, but also market trust among hospitals and clinicians who are increasingly scrutinising the governance of AI in their clinical workflows.

Impact

Structural facts

42%of Dutch organisations deploy AI (CBS 2026)
Aug 2026EU AI Act high-risk compliance deadline
MDCG 2025-6new guidance on AI in medical devices
73%of organisations experience AI talent shortage (CBS 2026)
Frequently asked questions

FAQ

What is dual EU AI Act × MDR compliance?

AI-driven medical devices fall under both the EU AI Act (high-risk classification) and the Medical Device Regulation. Both require conformity assessments, documentation and quality assurance systems. MDCG 2025-6 provides guidance on integration.

What does MDCG 2025-6 mean for MedTech?

MDCG 2025-6 provides concrete guidance on AI in medical devices: bias mitigation, transparency and the proposal to integrate EU AI Act and MDR conformity assessments. It is the first official bridge between both regulations.

Must every AI update be MDR-recertified?

Potentially yes. Significant changes to AI algorithms in medical devices can require recertification under MDR. Governance-by-design — building compliance into the development process — is the most efficient approach.

How does medical AI integrate with EHR systems?

Medical AI must be HL7 FHIR-compliant for interoperability with EHR systems. AlphaIndigo helps design governance-grade integration architecture that meets NEN 7510 and MDR requirements.

How long does an AI Opportunity Scan take for MedTech?

The Scan is delivered within the standard 2–4 week timeframe. For MedTech, the Scan includes an EU AI Act × MDR dual compliance gap analysis, MDCG 2025-6 assessment and QMS integration review.

Your Team

CAICO- and CAITL-certified leadership team

AlphaIndigo practitioners combine sector experience in healthcare and life sciences with certified AI governance expertise. Our team operates as embedded leaders — not external advisers who leave reports behind.

Meet the team →

Book an AI Opportunity Scan for your MedTech company

Within the standard Scan timeframe, you gain visibility on gaps for EU AI Act × MDR dual compliance, MDCG 2025-6 and QMS integration — and a prioritised roadmap.